SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001607062-18-000471
Filing Date
2018-12-04
Accepted
2018-12-03 17:36:34
Documents
20
Period of Report
2018-12-03
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K gnbt120318form8k.htm 8-K 26598
2 EXHIBIT 99.1 ex99_1.htm EX-99.1 74999
3 EXHIBIT 99.2 ex99_2.htm EX-99.2 23549
4 GRAPHIC image_001.jpg GRAPHIC 20223
5 GRAPHIC image_002.jpg GRAPHIC 81035
6 GRAPHIC image_003.jpg GRAPHIC 52473
7 GRAPHIC image_004.jpg GRAPHIC 36583
8 GRAPHIC image_005.jpg GRAPHIC 41543
9 GRAPHIC image_006.jpg GRAPHIC 41941
10 GRAPHIC image_007.jpg GRAPHIC 52931
11 GRAPHIC image_008.jpg GRAPHIC 38757
12 GRAPHIC image_009.jpg GRAPHIC 45547
13 GRAPHIC image_010.jpg GRAPHIC 59161
14 GRAPHIC image_011.jpg GRAPHIC 55757
15 GRAPHIC image_012.jpg GRAPHIC 51035
16 GRAPHIC image_013.jpg GRAPHIC 55329
17 GRAPHIC image_014.jpg GRAPHIC 48164
18 GRAPHIC image_015.jpg GRAPHIC 42656
19 GRAPHIC image_016.jpg GRAPHIC 59918
20 GRAPHIC image_017.jpg GRAPHIC 18730
  Complete submission text file 0001607062-18-000471.txt   1232650
Mailing Address 10102 USA TODAY WAY MIRAMAR FL 33025
Business Address 10102 USA TODAY WAY MIRAMAR FL 33025 416-364-2551
GENEREX BIOTECHNOLOGY CORP (Filer) CIK: 0001059784 (see all company filings)

IRS No.: 820490211 | State of Incorp.: DE | Fiscal Year End: 0731
Type: 8-K | Act: 34 | File No.: 000-25169 | Film No.: 181214891
SIC: 2834 Pharmaceutical Preparations